Found: 3
Select item for more details and to access through your institution.
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 623, p. 1, doi. 10.1126/scitranslmed.abh1962
- By:
- Publication type:
- Article
Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1096, doi. 10.3390/ijms22031096
- By:
- Publication type:
- Article
Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0197349
- By:
- Publication type:
- Article